TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Virologic Response and Safety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With COVID-19.

Mahta Mortezavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.